Quintiles’ Fourth Quarter 2013 Earnings Call Scheduled for Thursday, February 13th
The conference call will be accessible, live via webcast, through the Investor Relations section of the Quintiles website at www.quintiles.com/investors. To participate via telephone, please dial +1 (855) 484-7367 in the United States or +1 (631) 259-7541 outside the United States, approximately 15 minutes before the scheduled start of the call.
An archived edition of the conference call will be available online at www.quintiles.com/investors after 1 p.m. EST on Thursday, February 13th.
About Quintiles
Quintiles (NYSE: Q) is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 28,000 employees conducting business in approximately 100 countries. We have helped develop or commercialize all of the top-50 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. To learn more about Quintiles, please visit www.quintiles.com
Click here (http://alerts.businesswire.com/subscribe/quintiles) to subscribe to Mobile Alerts for Quintiles.
Website: http://www.quintiles.com
Contact
Quintiles
Phil Bridges, + 1-919-998-1653
Mobile: +1-919-457-6347
phil.bridges@quintiles.com
Investor Relations
Karl Deonanan, +1-919-998-2789
InvestorRelations@quintiles.com
This news is a press release provided by Quintiles. Korea Newswire follows these editorial guidelines.
-
2016년 8월 30일 13:40